References
- Sellers E M, Naranjo C A, Harrison M, et al. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34: 822–826
- Gross G A. The use of propranolol as a method to manage acute alcohol detoxification. J Am Osteopath Assoc 1982; 82: 206–207
- Kraus M L, Gottlieb L D, Horwitz R L, et al. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313: 905–909
- Baumgartner G R, Rowen R C. Clonidine vs. chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 107: 880–884
- Brunning J, Mumford J P, Keaney F P. Lofexidine in alcohol withdrawal states. Alcohol 1986; 21: 167
- Banger M, Benkert O, Roschke J, et al. Nimodipine in acute alcohol withdrawal state. J Psychiatr Res 1992; 26: 117–123
- Gatti A, Munari L, Perretti A, et al. Sequential nimodipine-reduced glutadiione treatment in alcoholic abstinence syndrome: preliminary experience. Minerva Med 1992; 83: 277–281
- Agricola R. Treatment of acute alcohol withdrawal syndrome with carbamazapine: a double-blind comparison with tiapride. J Int Med Res 1982; 10: 160–165
- Ballenger J C, Post R M. Mechanism of action of carbamazepine and anticonvulsants in affective illness. Psychopharmacology: The Third Generation of Progress, H Meltzer, B S Bunney, Jr. Raven, New York 1987; 567–576
- Malcolm R, Ballenger J C, Sturgis E T, et al. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146: 617–621
- Ries R K, Roy-Byrne P P, Ward N G, et al. Carbamazepine treatment for benzodiazepine withdrawal. Am J Psychiatry 1989; 146: 536–537
- Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64: 254–259
- Shaw G K. Alcohol dependence and withdrawal. Br Med Bull 1982; 38: 99–102
- Gessner P K. Drug therapy of the alcohol withdrawal syndrome. The Biochemistry and Pharmacology of Ethanol, E Majchrowicz, E Noble. Plenum, New York 1979; 375–434
- Wilbur R, Kulik F A. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. Am J Hosp Pharm 1981; 38: 1138–1143
- Lambie D G, Johnson R H, Vijayasenan M E, et al. Sodium valproate in the treatment of the alcohol wididrawal syndrome. Aust N Z J Psychiatry 1980; 14: 213–215
- Hillbom M, Tokola R, Kuusela V, et al. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 1989; 6: 223–226
- Roy-Byrne P P, Ward N G, Donnelly P J. Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 1989; 50: 44–48
- VoIpicelli J, O'Brien C, Alterman A, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 867–880
- O'Malley S S, Jaffe A J, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 49: 894–898
- Sellers E M, Higgins G A, Sobell M B. 5-HT and alcohol abuse. Trends Pharmacol Sci 1992; 13: 69–75
- Bruno F, Casten G. Buspirone treatment of alcoholic patients. Data presented at the Hospital and Community Psychiatry Meeting. Boston, MA 1987
- Monti J M, Alterwain P. Ritanserin decreases alcohol intake in chronic alcoholics (letter). Lancet 1991; 337: 60
- Naranjo C A, Kadlec K E, Sanhueza P, et al. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47: 490–498
- Naranjo C A, Sullivan J T, Kadlec K E, et al. Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 1989; 46: 301–309
- Naranjo C A, Sellers E M, Sullivan J T, et al. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 1987; 41: 266–274
- Charney D S, Riordan C E, Kleber H D, et al. Clonidine and naltrexone: a safe, effective and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry 1982; 39: 1327–1332
- Gold M S, Redmond D E, Kleber H D. Clonidine for opiate withdrawal. Lancet 1978; 1: 929–930
- Kleber H D, Topazian M, Gaspari J, et al. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1987; 13: 1–18
- Vining E, Kosten T R, Kleber H D. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988; 83: 567–575
- Kleber H D, Riordan C E, Rounsaville B J, et al. Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry 1985; 42: 391–398
- Kosten T R, Kleber H D. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sci 1988; 42: 635–641
- Lewis J W. Buprenorphine. Drug Alcohol Depend 1985; 14: 363–372
- Kosten T R, Krystal J H, Morgan C H, et al. Rapid detoxification using buprenorphine and naloxone (letter). Am J Psychiatry 1989b; 146: 1349
- Shi J M, O'Connor P G, Constantino J A, et al. Three methods of ambulatory opiate detoxification: preliminary results of a randomized clinical trial. NIDA Research Monograph #132 (NIH Publ No 93–3505), U. S. Government Printing Office, Washington, DC 1993; 309
- Blaine J D, Thomas D B, Barnett G, . Levo-alpha-acetylmethadol (LAAM): clinical utility and pharmaceutical development. Substance Abuse. - Clinical Problems and Perspectives, J H Lowinson, P Ruiz, et al. Williams & Wilkins, Baltimore, MD 1981; 360–388
- Ling W, Charuvastra V C, Kain S C, et al. Methadyl acetate and methadone as maintenance treatment for heroin addicts. Arch Gen Psychiatry 1976; 33: 709–712
- Jasinski D R, Pevnick J S, Griffith J D. Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 1978; 35: 510–516
- Johnson R E, Fudala P J, Jaffe J H. A controlled trial of buprenorphine for opioid dependence. JAMA 1992; 267: 2750–2755
- Kosten T R, Schottenfeid R S, Ziedonis D, et al. Buprenorphine vs. methadone maintenance for opioid dependence. J Nerv Ment Dis 1993; 181: 358–364
- Bickel W K, Stitzer M L, Bigelow G E, et al. Buprenorphine: dose-related blockade of opioid challenge effects in opioid-dependent humans. J Pharmacol Exp Ther 1989; 247: 47–53
- Schottenfeid R S, Pakes J, Ziedonis D M, et al. Buprenorphine: dose-related effects on cocaine and opiate use in cocaine-abusing, opioid-dependent humans. Biol Psychiatry 1993; 34: 66–74
- Quigley A J, Bredemeyer D E, Seow S S. A case of buprenorphine abuse. Med J Aust 1984; 142: 425–426
- Tennant F S, Sagherian A A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 1987; 147: 109–112
- Morgan C H, Kosten T R, Gawin F H, et al. A pilot trial of amantadine for cocaine abuse. NIDA Res MonogrSer 1988; 81: 81–85
- Weddington W W, Brown B S, Haertzen C A, et al. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17: 137–152
- Dackis C A, Gold M S, Sweeney D R, et al. Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987; 20: 261–264
- Giannini A J, Baumgartel P. Bromocriptine in cocaine withdrawal. J Clin Pharmacol 1987; 27: 267–270
- Kosten T R, Morgan C M, Falcioni J, et al. Pharmacotherapy for cocaine-abusing, methadone-matn-tained patients using amantadine or desipramine. Arch Gen Psychiatry 1992a; 49: 894–399
- Khantzian E J, Gawin F, Kleber H D, et al. Methyl-. phenidate (Ritalin) treatment of cocaine dependence: a preliminary report. J Subst Abuse Treat 1984; 1: 107–112
- Diakogiannis I A, Steinberg M, Kosten T R. Mazindol treatment of cocaine abuse: a double-blind investigation. NIDA Res Monogr Ser, 1990; 105: 514
- Margolin A, Kosten T, Petrakis I, et al. Bupropion reduces cocaine abuse in methadone-maintained patients (letter). Arch Gen Psychiatry 1991; 48: 87
- Gawin F H, Allen D, Humblestone B. Outpatient treatment of “crack” cocaine smoking with flu-penthixol decanoate. Arch Gen Psychiatry 1989a; 46: 322–325
- Gawin F H, Kleber H D, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989b; 46: 117–121
- Levin F R, Lehman A F. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharmacol 1991; 11: 374–378
- Kosten T R, Silverman D G, Fleming J, et al. Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatry 1992b; 32: 543–548
- Arndt I O, Dorozynsky L, Woody G E, et al. Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry 1992; 49: 888–893
- Weiss R D. Relapse to cocaine abuse after initiating desipramine treatment. JAMA 1988; 260: 2545–2546
- Pollack M H, Rosenbaum J F. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry 1991; 52: 31–33
- Batki S L, Manfredi L B, Jacob P I I I, et al. Fluoxetine for cocaine dependence in merhadone-mainte-nance: quantitative plasma and urine cocaine/ benzoylecognine concentration. J Clin Psycho-pharm 1993; 13: 243–250
- Kosten T A, Kosten T R, Gawin F H, et al. An open trial of sertraline for cocaine abuse. American Journal on Addictions 1992; 1: 349–353
- Jenkins S W, Warfield N A, Blaine J D, et al. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharm Bull 1992; 28: 21–26
- Carroll K, Ziedonis D, O'Malley S, et al. Pharmacologic interventions for abusers of alcohol and cocaine: disulfiram vs. naltrexone. American Journal on Addictions 1993; 2: 77–79
- Halikas J, Kemp K, Kuhn K, et al. Carbamazepine for cocaine addiction?. Lancet 1989; 1: 623–624
- Hatsukami D, Keenan R, Halikas J, et al. Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psycho-pharmacol 1991; 104: 120–124
- Gorelick D A, Weinhold U, Henningfield J E. Carbamazepine (CBZ) does not alter cocaine self-administration in human cocaine addicts (abstract). Committee on Problems of Drug Dependence Annual Scientific Meeting. 1993
- Kosten T R, Kleber H D, Morgan C H. Treatment of cocaine abuse using buprenorphine. Biol Psychiatry 1989a; 26: 637–639
- Fudala P J, Johnson R E, Jaffe J H. Outpatient comparison of buprenorphine and methadone maintenance, II: effects on cocaine usage, retention time in study, and missed clinic visits. Committee on Problems of Drug Dependence, 1990, L S Harris. NIDA Research Monograph 105, DHHS Pub. No. (ADM)91–1753, Supt. of Documents, U. S. Government Printing Office, Washington, DC 1991; 587–588
- Oliveto A H, Kosten T R, Schottenfeld R, et al. A comparison of cocaine use in buprenorphine-and methadone-maintained cocaine users. American Journal on Addictions 1994; 3: 43–48
- Ziedonis D M, Kosten T R. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27: 337–343